Skip to content
DefDex

Federal award

NOVA BIOMEDICAL CORP

W81K0017P0439

Contract

Obligated and Ceiling

Obligated (net)
$98,860.36
Ceiling (potential value, not spending)
$98,860.36
Current value
$98,860.36
Gross positive obligations
$113,460.00

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
NOVA BIOMEDICAL CORP · LCFDHTGXB5J3
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
NOVA BIOMEDICAL CORP · LCFDHTGXB5J3
Awarding agency
Department of War · sub-agency 2100 · office W81K00
Funding agency
Department of War · sub-agency 2100
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
W81K0017P0439
Award type code
B
Actions
11 · Jun 1, 2017 to Oct 22, 2020
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History11

Award actions
DateFYModAction typeObligationCompany in company totals
Oct 22, 2020FY2021P00010C$22,644.00
—
Aug 6, 2020FY2020P00009C−$14,599.64
—
Jun 18, 2020FY2020P00008G$0.00
—
Oct 16, 2019FY2020P00007C$22,644.00
—
Sep 10, 2019FY2019P00006G$0.00
—
Dec 12, 2018FY2019P00005C$22,644.00
—
Sep 20, 2018FY2018P00004C$420.00
—
Sep 12, 2018FY2018P00003G$0.00
—
Oct 31, 2017FY2018P00002C$22,644.00
—
Aug 8, 2017FY2017P00001G$0.00
—
Jun 1, 2017FY20170—$22,464.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.